Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Naples, Italy, 20133 to the Locations list and removed Napoli, Italy, 20133.
    Difference
    0.0%
    Check dated 2026-03-25T21:22:25.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been published, replacing the prior revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T18:04:02.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.4.3 implemented, replacing v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T17:40:12.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. This reflects a routine version update in the site's revision history.
    Difference
    0.0%
    Check dated 2026-02-17T04:49:11.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The study page now shows 217 locations, and multiple investigator contacts and site entries (e.g., Istanbul, Ankara, and Seoul St. Mary’s Hospital) have been removed, changing the total location count.
    Difference
    0.3%
    Check dated 2026-02-09T00:47:20.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Glossary toggle added; page metadata updated to include Last Update Submitted that Met QC Criteria and Last Update Posted. The revision is updated to v3.4.0 and older No FEAR Act data entries were removed.
    Difference
    0.0%
    Check dated 2026-01-25T18:19:34.000Z thumbnail image

Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.